Entity Details

Primary name MYH14_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ7Z406
EntryNameMYH14_HUMAN
FullNameMyosin-14
TaxID9606
Evidenceevidence at protein level
Length1995
SequenceStatuscomplete
DateCreated2005-07-19
DateModified2021-06-02

Ontological Relatives

GenesMYH14

GO terms

Show/Hide Table
GOName
GO:0000146 microfilament motor activity
GO:0001725 stress fiber
GO:0003009 skeletal muscle contraction
GO:0005516 calmodulin binding
GO:0005524 ATP binding
GO:0005829 cytosol
GO:0005903 brush border
GO:0007519 skeletal muscle tissue development
GO:0007605 sensory perception of sound
GO:0008360 regulation of cell shape
GO:0016020 membrane
GO:0016460 myosin II complex
GO:0016887 ATP hydrolysis activity
GO:0019228 neuronal action potential
GO:0030048 actin filament-based movement
GO:0030426 growth cone
GO:0031032 actomyosin structure organization
GO:0042641 actomyosin
GO:0051015 actin filament binding
GO:0070062 extracellular exosome
GO:0070584 mitochondrion morphogenesis
GO:0071625 vocalization behavior
GO:0097513 myosin II filament

Subcellular Location

Show/Hide Table

Domains

Show/Hide Table
DomainNameCategoryType
IPR000048 IQ motif, EF-hand binding siteSiteBinding site
IPR001609 Myosin head, motor domainDomainDomain
IPR002928 Myosin tailDomainDomain
IPR004009 Myosin, N-terminal, SH3-likeDomainDomain
IPR008989 Myosin S1 fragment, N-terminalFamilyHomologous superfamily
IPR027417 P-loop containing nucleoside triphosphate hydrolaseFamilyHomologous superfamily
IPR036961 Kinesin motor domain superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
600652 OMIMDeafness, autosomal dominant, 4A (DFNA4A)A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. The disease is caused by variants affecting the gene represented in this entry.
614369 OMIMPeripheral neuropathy, myopathy, hoarseness, and hearing loss (PNMHH)A complex phenotype of progressive peripheral neuropathy and distal myopathy, with later onset of hoarseness and hearing loss. Affected individuals develop distal muscle weakness at a mean age of 10.6 years, followed by progressive atrophy of these muscles. The lower limbs are more severely affected than the upper limbs, and the muscle weakness first affects anterior leg muscles and later posterior leg muscles. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB01944 (S)-blebbistatinDrugbanksmall molecule
DB03126 Mant-AdpDrugbanksmall molecule
DB04444 Tetrafluoroaluminate IonDrugbanksmall molecule
DB07468 (3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-oneDrugbanksmall molecule
DB07469 (3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-oneDrugbanksmall molecule
DB07470 (3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-oneDrugbanksmall molecule
DB08276 trifluoro-[hydroxy-[hydroxy-[2-(N-methyl-2-nitro-anilino)ethoxy]phosphoryl]oxy-phosphoryl]oxy-beryllium(1-)Drugbanksmall molecule